Evaluación pronóstica del score PADIT para la predicción de infección asociada a dispositivos cardíacos implantables en población colombiana

dc.contributor.advisorMora Pabón, Guillermo
dc.contributor.authorBastidas Narváez, Andrea Milena
dc.contributor.educationalvalidatorRojas Ruiz Ingrid Tatiana
dc.contributor.researcherGarcía Moncayo, Andrea Lorena
dc.date.accessioned2022-08-18T16:37:41Z
dc.date.available2022-08-18T16:37:41Z
dc.date.issued2022-08-15
dc.descriptionilustraciones, graficasspa
dc.description.abstractIntroducción. Actualmente, los dispositivos electrónicos cardiovasculares implantables se convirtieron en el pilar fundamental del tratamiento de pacientes con arritmias, sin embargo, una de las complicaciones asociadas a su uso consiste la infección, su presencia es equivalente a mayor morbilidad y mortalidad. El objetivo principal de este estudio es evaluar el desempeño pronóstico del score PADIT, escala diseñada para identificar a pacientes con riesgo de infección. Métodos. Se realizó un estudio observacional con componente analítico de cohorte retrospectiva en pacientes atendidos en los últimos 6 años en el servicio de electrofisiología. En el Hospital Universitario Clínica San Rafael se atendieron 3745 pacientes portadores de dispositivos electrónicos implantables cardiacos en el periodo descrito. En el estudio se recogió datos de 1780 pacientes, teniendo en cuenta los criterios de inclusión y exclusión. Resultados. De los pacientes incluidos 953 (54%) fueron de género masculino y 827 (46%) de femenino, la edad predominante fue mayor de 69 años; se encontraron diferentes variables relacionadas con infección, como la edad (p=0,01), el antecedente de insuficiencia cardiaca (p=0,007), el ingreso hospitalario reciente (p=0,000), el tipo de intervención (p=0,013), entre otros. Al realizar el índice de Youden, se encontró con un índice de confianza del 95%, que el score PADIT tiene un área bajo la curva mayor a 0,5 en las tres puntuaciones de riesgo (bajo, moderado y alto). Conclusiones. Se concluye que el score PADIT tiene desempeño regular en la predicción de infección en la población analizada. (Texto tomado de la fuente)spa
dc.description.abstractIntroduction. Currently, implantable cardiovascular electronic devices have become the mainstay of treatment for patients with arrhythmias, however, one of the complications associated with their use is infection, their presence is equivalent to increased morbidity and mortality. The main objective of this study is to evaluate the prognostic performance of the PADIT score, a scale designed to identify patients at risk of infection. Methods. An observational study with an analytical component of a retrospective cohort was carried out in patients treated in the last 6 years in the electrophysiology service. At the Hospital Universitario Clinical San Rafael, 3,745 patients with cardiac implantable electronic devices were treated in the period described. The study collected data from 1,780 patients, taking into account the inclusion and exclusion criteria. Results. Of the patients included, 953 (54%) were male and 827 (46%) female, the predominant age was over 69 years; different variables related to infection were found, such as age (p=0.01), history of heart failure (p=0.007), recent hospital admission (p=0.000), type of intervention (p=0.013), among others. When performing the Youden index, it was found with a confidence index of 95%, that the PADIT score has an area under the curve greater than 0.5 in the three risk scores (low, moderate and high). Conclusions. It is concluded that the PADIT score has regular performance in predicting infection in the analyzed population.eng
dc.description.degreelevelEspecialidades Médicasspa
dc.description.degreenameEspecialista en Medicina Internaspa
dc.description.methodsEstudio observacional analítico de cohorte retrospectivaspa
dc.format.extent70 páginasspa
dc.format.mimetypeapplication/pdfspa
dc.identifier.instnameUniversidad Nacional de Colombiaspa
dc.identifier.reponameRepositorio Institucional Universidad Nacional de Colombiaspa
dc.identifier.repourlhttps://repositorio.unal.edu.co/spa
dc.identifier.urihttps://repositorio.unal.edu.co/handle/unal/81950
dc.language.isospaspa
dc.publisherUniversidad Nacional de Colombiaspa
dc.publisher.branchUniversidad Nacional de Colombia - Sede Bogotáspa
dc.publisher.departmentDepartamento de Medicina Internaspa
dc.publisher.facultyFacultad de Medicinaspa
dc.publisher.placeBogotá, Colombiaspa
dc.publisher.programBogotá - Medicina - Especialidad en Medicina Internaspa
dc.relation.indexedRedColspa
dc.relation.indexedLaReferenciaspa
dc.relation.referencesArber N, P. E. (1994). Pacemaker endocarditis. Report of 44 cases and review of the literature. Medicine (Baltimore) , 73:299spa
dc.relation.referencesBaddour Larry M., A. E. (2010). Update on Cardiovascular Implantable Electronic Device Infections and Their Management. Circulation, 121:458–477spa
dc.relation.referencesBaddour LM, C. Y. (2012). Clinical practice. Infections of cardiovascular implantable electronic devices. N Engl J Med , 367:842spa
dc.relation.referencesBaddour LM, W. W. (2005). Infections of prosthetic valves and intravascular devices. Principles and Practice of Infectious Diseases, 6th ed, Mandell GL, Bennett JE, Dolin R (Eds), Churchill Livingstone, Philadelphia , 102spa
dc.relation.referencesBongiorni MG, B. H. (2018). ESC Scientific Document Group. 2018 EHRA expert consensus statement on lead extraction: recommendations on definitions, endpoints, research trial design, and data collection requirements for clinical scientific studies and registries: endorsed by APHRS/HR. Europace , 20: 1217–1217spa
dc.relation.referencesC., D. D. (2018). Approach to Diagnosis of Cardiovascular Implantable-Electronic-Device Infection. Journal of Clinical Microbiology, volume 56, Issue 7spa
dc.relation.referencesCacoub P, L. P. (1998). Pacemaker infective endocarditis. . Am J Cardiol , 82:480.spa
dc.relation.referencesCarina, B.-L. (2020). European Heart RhythmAssociation (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections. European Heart Journal, 41, 2012–2032.spa
dc.relation.referencesChua JD, W. B. (2000). Diagnosis and management of infections involving implantable electrophysiologic cardiac devices. Ann Intern Med, 133:604spa
dc.relation.referencesDa Costa A, L. H. (1998). Role of the preaxillary flora in pacemaker infections. Circulation, 97:1791–1795spa
dc.relation.referencesDai M, C. C. (2019). Trends of Cardiovascular Implantable Electronic Device Infection in 3 Decades: A Population-Based Study. JACC Clin Electrophysiol, 5:1071spa
dc.relation.referencesDarouiche RO, W. M. (2010 ). Chlorhexidine-Alcohol versus Povidone-Iodine for Surgical-Site Antisepsis. N Engl J Med, 362(1):18-26spa
dc.relation.referencesDeSimone DC, S. M. (2019). Contemporary management of cardiac implantable electronic device infection. Heart , 105:961spa
dc.relation.referencesDuval X, S.-S. C. (2004). Endocarditis in patients with a permanent pacemaker: a 1-year epidemiological survey on infective endocarditis due to valvular and/or pacemaker infection. Clin Infect Dis , 39:68spa
dc.relation.referencesEggimann P, W. F. (2000). Pacemaker and defibrillator infections. In: Infections Associated with Indwelling Medical Devices, Waldvogel FA, Bisno AL (Eds). American Society for Microbiology Press, 247spa
dc.relation.referencesErba PA, L. P. (2018). Recommendations on nuclear and multimodality imaging in IE and CIED infections. Eur J Nucl Med Mol Imaging , 45:1795–1815spa
dc.relation.referencesEsquer Garrigos Z, S. M.-Q. (2020). Molecular Approach to Diagnosis of Cardiovascular Implantable Electronic Device Infection. . Clin Infect Dis , 70:898spa
dc.relation.referencesFozia Z Ahmed, 1. C.-L., & Bloom, H. (2021). Use of healthcare claims to validate the Prevention of Arrhythmia Device Infection Trial cardiac implantable electronic device infection risk score. Europace, 23(9): 1446–1455spa
dc.relation.referencesGreenspon AJ, P. J. (2011). 16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008. J Am Coll Cardiol, 58:1001spa
dc.relation.referencesH, B. D. (2019). Risk Factors for Infections Involving Cardiac Implanted Electronic Devices. Journal of the American College of Cardiology, Volume 74, Issue 23, Pages 2845-2854spa
dc.relation.referencesHabib G, L. P. (2015). ESC Scientific Document Group. 2015 ESC Guidelines for the management of infective endocarditis: the Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: european Association for Cardio-Thoracic. Eur Heart J , 36:3075–3128spa
dc.relation.referencesHossein Sadeghi, M. (2018). New Insights into Predictors of Cardiac Implantable Electronic Device Infection. Tex Heart Inst J, 45(3): 128–135spa
dc.relation.referencesHui-Chen Han, H. N. (2021). Epidemiology of cardiac implantable electronic device infections: incidence and risk factors. Europace, 23, iv3–iv10spa
dc.relation.referencesHussein AA, B. Y. (2016). Microbiology of cardiac implantable electronic device infections. . JACC Clin Electrophysiol , 2:498–505spa
dc.relation.referencesJN, C. (1994). Pathology of cardiac pacemakers and central catheters. . Curr Top Pathol , 86:199spa
dc.relation.referencesJorge, C.-P. (2019). Proposal for a Novel Score to Determine the Risk of Cardiac Implantable Electronic Device Infection. Rev Esp Cardiol, Volume 72, Issue 10, Pages 806-812spa
dc.relation.referencesJoy PS, K. G. (2017). Cardiac implantable electronic device infections: Who is at greatest risk? Heart Rhythm, 14:839spa
dc.relation.referencesKlug D, B. M. (2007). Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: results of a large prospective study. Circulation, 116:1349spa
dc.relation.referencesKlug D, L. D. (1997). Systemic infection related to endocarditis on pacemaker leads: clinical presentation and management. Circulation, 95:2098spa
dc.relation.referencesKnigina L, K. C. (2010). Treatment of patients with recurrent or persistent infection of cardiac implantable electronic devices. . Europace , 12:1275–1281spa
dc.relation.referencesKrahn Andrew D., Y. L. (2018 ). Prevention of Arrhythmia Device Infection Trial: The PADIT Trial. J Am Coll Cardiol, 72 (24) 3098–3109spa
dc.relation.referencesKusumoto FM, S. M.-G. (2017). 2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction. Heart Rhythm , 14:e503–e551spa
dc.relation.referencesKusumoto Fred M, M. H. (2019). Bradycardia Clinical Practice Guidelines. Circulation, 140:e382–e482spa
dc.relation.referencesLe KY, S. M. (2011). Impact of timing of device removal on mortality in patients with cardiovascular implantable electronic device infections. Heart Rhythm, 8:1678spa
dc.relation.referencesLebeaux D, F. ́.-H.-M. (2014). Management of infections related to totally implantable venous access ports: challenges and perspectives. Lancet Infect Dis , 14:146–159spa
dc.relation.referencesLi JS, S. D. (2000). Proposed modifications to the duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis , 30:633–638spa
dc.relation.referencesM, S. M. (2019). Cardiac Implantable Electronic Device Therapy: Permanent Pacemakers, Implantable Cardioverter Defibrillators, and Cardiac Resynchronization Devices. Med Clin North Am, 103(5):931-943spa
dc.relation.referencesMittal Suneet, S. R. (2014 ). Cardiac implantable electronic device infections: incidence, risk factors, and the effect of the AigisRx antibacterial envelope. Heart Rhythm, 11(4):595-601spa
dc.relation.referencesMorishita A, S. T. (2001). Treatment strategy for infections in patients with permanent pacemakers. Journal of Artificial Organs. , 4:193-7spa
dc.relation.referencesMuhammad Irfan, I. K. (2020). Delays in Temporary and Permanent Pacemakers: Causes and In-Hospital Outcomes. Cureus, 12(2): e6953spa
dc.relation.referencesMulpuru SK, P. V.-G. (2013). Device infections: management and indications for lead extraction. Circulation , 128:1031spa
dc.relation.referencesNagpal A, P. R.-Q. (2015). Usefulness of sonication of cardiovascular implantable electronic devices to enhance microbial detection. Am J Cardiol , 115:912spa
dc.relation.referencesNakajima I, N. R. (2021). Staphylococcus bacteremia without evidence of cardiac implantable electronic device infection. Heart Rhythm , 18:752spa
dc.relation.referencesOlsen T, J. O. (2019). Incidence of device-related infection in 97 750 patients: clinical data from the complete Danish device-cohort (1982-2018). Eur Heart J, 40:1862spa
dc.relation.referencesOrtega Calvo Manuel, C. D. (2002). Regresión logística no condicionada y tamaño de muestra: una revisión bibliográfica. Rev. Esp. Salud Pública, 85-93spa
dc.relation.referencesPatel D, K. F. (2015). Cardiac implantable electronic device lead extraction in patients with underlying infection using open thoracotomy or percutaneous techniques. Cardiol J , 22:68–74spa
dc.relation.referencesPeacock JE, S. J. (2018). Attempted salvage of infected cardiovascular implantable electronic devices: are there clinical factors that predict success? Pacing. Clin Electrophysiol , 41:524–531spa
dc.relation.referencesPolyzos KA, K. A. (2015). Risk factors for cardiac implantable electronic device infection: a systematic review and meta-analysis. Europace, 17:767spa
dc.relation.referencesPrutkin JM, R. M. (2014). Rates of and factors associated with infection in 200 909 Medicare implantable cardioverter-defibrillator implants: results from the National Cardiovascular Data Registry. Circulation , 130:1037spa
dc.relation.referencesRO, D. (2001). Device-associated infections: a macroproblem that starts with microadherence. Clin Infect Dis , 33:1567–1572spa
dc.relation.referencesRosso, F. (2016). Infección relacionada con los dispositivos cardiovasculares. Rev. Colomb. Cardiol, vol.23 no.6spa
dc.relation.referencesRusanov A, S. H. (2010). A 15-year experience with permanent pacemaker and defibrillator lead and patch extractions. Ann Thorac Surg , 89:44–50spa
dc.relation.referencesSandoe JA, B. G. (2015). Guidelines for the diagnosis, prevention and management of implantable cardiac electronic device infection. Report of a joint Working Party project on behalf of the British Society for Antimicrobial Chemotherapy (BSAC, host organization), British Heart Rh. J Antimicrob Chemother , 70:325–359spa
dc.relation.referencesSchaerf RHM, N. S. (2016). Percutaneous vacuum-assisted thrombectomy device used for removal of large vegetations on infected pacemaker and defibrillator leads as an adjunct to lead extraction. J Atr Fibrillation , 9:1455spa
dc.relation.referencesSohail MR, H. C.-F. (2011). Mortality and cost associated with cardiovascular implantable electronic device infections. Arch Intern Med , 171:1821spa
dc.relation.referencesSohail MR, U. D. (2007). Risk factor analysis of permanent pacemaker infection. Clin Infect Dis, 45:166spa
dc.relation.referencesSpittell PC, H. D. (1992). Venous complications after insertion of a transvenous pacemaker. . Mayo Clin Proc , 67:258spa
dc.relation.referencesStarck CT, E.-G. J.-D. (2018). Managing large lead vegetations in transvenous lead extractions using a percutaneous aspiration technique. Expert Rev Med Devices, 15:757–761spa
dc.relation.referencesSuarez, K. (2019). A Review of Temporary Permanent Pacemakers and a Comparison with Conventional Temporary Pacemakers. J Innov Card Rhythm Manag, 10(5): 3652–3661spa
dc.relation.referencesTan EM, D. D. (2017). Outcomes in patients with cardiovascular implantable electronic device infection managed with chronic antibiotic suppression. Clin Infect Dis , 64: 1516–1521spa
dc.relation.referencesTarakji KG, C. E. (2010). Cardiac implantable electronic device infections: presentation, management, and patient outcomes. Heart Rhythm , 7:1043spa
dc.relation.referencesUslan DZ, S. M. (2007). Permanent pacemaker and implantable cardioverter defibrillator infection: a population-based study. . Arch Intern Med, 67:669–675spa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.rights.licenseAtribución-NoComercial-SinDerivadas 4.0 Internacionalspa
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/spa
dc.subject.ddc610 - Medicina y salud::616 - Enfermedadesspa
dc.subject.otherDispositivos electrónicos cardíacos implantables (CIED)
dc.subject.othermarcapasos (PPM)
dc.subject.otherDesfibriladores automáticos implantables (DCI)
dc.subject.proposalInfecciónspa
dc.subject.proposaldispositivos cardiacos implantablesspa
dc.subject.proposalfactores de riesgospa
dc.subject.proposalscore PADITspa
dc.subject.proposalInfectioneng
dc.subject.proposalimplantable cardiac deviceseng
dc.subject.proposalrisk factorseng
dc.subject.proposalPADIT scoreeng
dc.titleEvaluación pronóstica del score PADIT para la predicción de infección asociada a dispositivos cardíacos implantables en población colombianaspa
dc.title.translatedPrognostic evaluation of the PADIT score for the prediction of infection associated with Implantable cardiac devices in the Colombian populationeng
dc.typeTrabajo de grado - Especialidad Médicaspa
dc.type.coarhttp://purl.org/coar/resource_type/c_bdccspa
dc.type.coarversionhttp://purl.org/coar/version/c_ab4af688f83e57aaspa
dc.type.contentTextspa
dc.type.driverinfo:eu-repo/semantics/masterThesisspa
dc.type.redcolhttp://purl.org/redcol/resource_type/TMspa
dc.type.versioninfo:eu-repo/semantics/acceptedVersionspa
dcterms.audience.professionaldevelopmentEstudiantesspa
dcterms.audience.professionaldevelopmentMaestrosspa
oaire.accessrightshttp://purl.org/coar/access_right/c_abf2spa

Archivos

Bloque original

Mostrando 1 - 1 de 1
Cargando...
Miniatura
Nombre:
1085301751.2022.pdf
Tamaño:
766.95 KB
Formato:
Adobe Portable Document Format
Descripción:
Tesis de Especialidad Médica en Medicina Interna

Bloque de licencias

Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
3.98 KB
Formato:
Item-specific license agreed upon to submission
Descripción: